Glywohn MP 1mg/500mg/15mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glywohn MP 1mg/500mg/15mg Tablet
Diabex Trio 1mg/500mg/15mg tablets offer triple-action blood sugar management. This combined medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood glucose. Always follow your physician's prescribed dosage and frequency for Diabex Trio. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. Excessive dosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart conditions, or if you are pregnant or breastfeeding. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Glywohn MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glywohn MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glywohn MP 1mg/500mg/15mg tablets with a meal.
Common Side effects of Glywohn MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glywohn MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glywohn MP 1mg/500mg/15mg tablets with a meal.
How Glywohn MP 1mg/500mg/15mg Tablet works:
Glywohn MP 1mg/500mg/15mg tablets combine the antidiabetic agents glimepiride, metformin, and pioglitazone, each acting via distinct pathways to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, diminishes hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glywohn MP 1mg/500mg/15mg Tablet with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glywohn MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Glywohn MP 1mg/500mg/15mg Tablet while breastfeeding is likely inadvisable. Available data from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glywohn MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. Glywohn MP 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glywohn MP 1mg/500mg/15mg tablets, as dose modification may be necessary. Consult a physician for guidance. Glywohn MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glywohn MP 1mg/500mg/15mg Tablet :
Should you forget a Glywohn MP 1mg/500mg/15mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glywohn MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Medication |
3,018 People bought this recently